Jamie Brannan

Executive Vice President and Chief Commercial Officer · Zoetis

Animal Health

Jamie Brannan leads Zoetis’ commercial organization after advancing through regional and international leadership in animal health.

Last reviewed: Nov 2, 2026

Jamie Brannan

Executive Vice President and Chief Commercial Officer
Zoetis

Last Reviewed: November 2, 2026

Executive Summary

Jamie Brannan leads Zoetis’ commercial organization after advancing through regional and international leadership in animal health.

Career Highlights

  • Became Zoetis’ first chief commercial officer in November 2024.
  • Previously led international operations, aquaculture and global diagnostics.
  • Chairs the Animal Health Institute board.

Professional Journey

Brannan began his working life as a microbiologist in laboratories in the United Kingdom before moving into commercial roles. He progressed through Ecolab’s healthcare division and later became general manager for the United Kingdom and Ireland at Mölnlycke Health Care.

He joined Zoetis in October 2016 as senior vice president of its Northern Europe cluster, covering the United Kingdom, Ireland and Nordic markets. In June 2021, he became president of international operations, expanding his responsibilities across the company’s markets outside the United States.

In November 2022, Brannan advanced to executive vice president and group president of international operations, aquaculture and global diagnostics. The position combined regional commercial leadership with responsibility for businesses serving fish producers and veterinary diagnostic customers.

Zoetis created the chief commercial officer position for him in November 2024. The appointment initially brought all global commercial markets under his oversight. His current portfolio includes international commercial operations, global commercial transformation and excellence, strategic accounts, diagnostics, aquaculture, BioDevices and precision animal health.

Alongside his company responsibilities, Brannan became chair of the Animal Health Institute board in May 2025. He was elected again in July 2026 for the 2026–2028 term, providing industry leadership on policy and regulatory priorities affecting companies that develop animal medicines and related products.

Education

Brannan earned an honors bachelor’s degree from Anglia Ruskin University.